Introduction
After working in medical device E&L studies for a while, you’ll notice a pattern:
Every time you send a new adhesive to a chemical characterization lab, the resulting spectrum always contains something not listed on the supplier’s MSDS.
This isn’t a lab error. The MSDS lists “ingredients in the formulation,” while E&L studies detect “compounds actually released by your product under specific conditions.” The difference between these two sets is exactly what risk assessment must tackle.
The four major adhesive systems have different chemical natures, so the gap between “what’s in the formulation” and “what actually leaches” varies. Understanding the risk characteristics of each system is the first step toward systematic evaluation.
E&L Risk Comparison Table for Four Major Adhesive Systems
| Dimension | UV-Curing Adhesive | Cyanoacrylate | Epoxy Resin | Silicone Adhesive |
|---|---|---|---|---|
| Primary Risk Compounds | Photoinitiators and their photodegradation products, residual monomers | Residual monomers, plasticizers | BPA/BPF residues, amine curing agent degradation products, brominated flame retardants | Low molecular weight siloxanes (D4/D5/D6), platinum catalyst residues |
| Genotoxic Concern Compounds | ITX, BP (some aromatic photoinitiators) | Certain plasticizer by-products | Bisphenol compounds | Currently low concern, but D4/D5 are under REACH review |
| Sterilization Compatibility Risks | Gamma radiation can trigger additional polymerization or chain scission | Relatively stable under gamma; EO sterilization requires attention to EO reaction products | High-temperature sterilization accelerates aging; gamma impact varies by formulation | Stable under gamma; EO may generate additional low molecular weight siloxanes |
| Adsorption Effects | Low | Low | Low | High — silicone may adsorb drug active ingredients, requires separate evaluation |
| Most Challenging Scenarios | Multiple photoinitiator photodegradation products appearing simultaneously | Large inter-batch variation in residual monomer levels | Dual risk stacking of bisphenol compounds plus brominated flame retardants | Bidirectional risks of adsorption vs. release |
Core Risk Logic for Each System
UV-Curing Adhesives: Photoinitiators Are the Primary Risk Source
The risk in UV-curing systems lies not only in the formulation itself, but also in whether the “curing reaction goes to completion.”
Photoinitiators are the key components that enable rapid curing of UV adhesives under ultraviolet light. However, complete curing depends on multiple variables: light source intensity, exposure time, adhesive layer thickness, substrate light transmission rate, and more.
In actual production, these variables are often difficult to control precisely. Once curing is incomplete, unreacted photoinitiators and monomers become the primary source of leachables.
Even more challenging: gamma ray sterilization itself is a form of high-energy radiation. It can cause bond cleavage in certain photoinitiator molecules without any UV light involvement, generating new compounds that didn’t exist in the original formulation — and naturally, these compounds won’t be on the MSDS.
Practical Recommendation: E&L studies for UV-curing adhesives must cover both “post-cured samples” and “post-cured + sterilized samples.”
Cyanoacrylate: Inter-Batch Variation Is an Overlooked Trap
Cyanoacrylate is widely used in disposable medical devices — assembling small plastic components, securing穿刺 needles (puncture needles), and connecting blood tubing. However, one often underestimated characteristic is that inter-batch variation can be significant.
Curing speed depends on ambient humidity (since water molecules trigger anionic polymerization), and humidity fluctuations in production environments are inevitable.
This means that even with identical formulations, the degree of cure completeness can vary between batches — leading to batch-to-batch fluctuations in residual monomer levels.
Practical Recommendation: When submitting E&L samples, require the lab to test at least 3 batches to assess inter-batch variation. If a supplier can provide multi-batch data, it indicates more systematic quality control.
Epoxy Resins: The Dual Challenge of Bisphenols and Flame Retardants
Epoxy resins have the most chemical risk overlaps among the four systems.
First, there’s the Bisphenol A (BPA) issue. Even “low-BPA” epoxy formulations struggle to achieve zero BPA residue. Both the FDA and EMA have extremely high concerns about BPA, and any review involving BPA requires additional safety argumentation.
Second, there’s the brominated flame retardant issue. Some functional epoxy formulations contain brominated flame retardants to meet fire resistance requirements — these flame retardants have already been added to the EU REACH SVHC (Substances of Very High Concern) candidate list.
Practical Recommendation: At the selection stage, require the supplier to provide complete formulation information (all additives, including CAS numbers). Don’t wait until the lab detects unknown peaks before trying to trace the source.
Silicone Adhesives: Adsorption Is a Bidirectional Risk
Among the four systems, silicone adhesives have the most unique risk logic — they not only “release substances” but can also “adsorb substances.”
Adsorption effects require particular attention in wearable devices. If silicone serves as a skin-contact sealing material and also contacts medications containing peptides or proteins, the silicone surface adsorption of these active ingredients could lead to inadequate drug dosing.
This is an independent safety issue different from “leachables.”
Practical Recommendation: For wearable devices or protein drug contact components involving silicone adhesives, evaluate both “leaching” and “adsorption” directions — not just one-way extraction studies.
Why Supplier MSDS Doesn’t Equal Your E&L Risk Assessment
The value of this comparison table goes beyond simply “remembering what risks each adhesive has.” More importantly, it reveals a systematic principle:
The E&L risk of an adhesive = formulation risk + process risk + usage condition risk. The intersection of all three defines your actual risk boundary.
Supplier MSDS only covers formulation risk (and in simplified form). Laboratory testing can cover process risk and usage condition risk — but only if you tell the lab what sterilization process you’re using, what media you’re contacting, and for how long.
This table isn’t an endpoint; it’s a starting point. Its value is giving you direction at the selection stage — knowing where the risk points are for each adhesive system and what to focus on during testing. Don’t assume everything is covered just because you have an MSDS.
Frequently Asked Questions
What is the most common mistake in adhesive E&L studies?
The most common mistake is testing only the cured adhesive without considering sterilization effects. Many adhesives — especially UV-curing and epoxy systems — can generate new leachable compounds after gamma or EO sterilization that don’t exist in the uncured material.
How do I choose between these adhesive systems for a medical device?
Selection should be based on the specific application: consider drug contact (proteins/peptides need silicone adsorption assessment), sterilization method (gamma compatibility varies significantly), and regulatory requirements (BPA and brominated flame retardants face heightened scrutiny).
Why do batch-to-batch differences matter so much for cyanoacrylate adhesives?
Cyanoacrylate cures through anionic polymerization triggered by moisture. Since production environment humidity fluctuates, even adhesives with identical formulations can have varying degrees of cure completeness, leading to different residual monomer levels between batches.
Can silicone adhesives affect drug delivery efficiency?
Yes. Silicone can adsorb active pharmaceutical ingredients, particularly proteins and peptides. In wearable devices or drug delivery systems, this adsorption may reduce the effective drug dose, creating a safety concern independent of leachable compounds.
Tags: UV-Curing Adhesive / Cyanoacrylate / Epoxy Resin / Silicone Adhesive / E&L Study / Medical Devices / Medical Device Chemical Characterization
Brunslab is a Chinese laboratory headquartered in Guangzhou, specializing in Extractables & Leachables (E&L) studies for pharmaceutical packaging and medical device materials. | Contact: Tel: +86 20 31068557 | Email: contact@brunslab.com
